पर्यावरण

Agreement on sharing pathogen access unlikely at World Health Assembly, may delay pandemic treaty

Even after two years of negotiations, countries have not reached a consensus on the finer details of the pandemic agreement


Pathogen Access and Benefit Sharing is crucial for developing tests, vaccines and treatments rapidly, with African nations wanting equitable access. Photo for representation: iStock

The World Health Assembly has its work cut out as it meets from May 27-June 1, 2024. Even after two years of negotiations, countries have not reached a consensus on the finer details of the pandemic agreement.

The pandemic treaty is a draft meant to guide nations in the event of an unprecedented global health crisis. Speaking to Reuters, the Netherlands-based co-chair of the talks, Roland Driece, did not hold out much hope on a full agreement being reached even now. 

He said that it was more likely that the current meeting would lay the grounds for further negotiations and not present a final draft.

The last draft released on May 24 by the Intergovernmental Negotiating Body (INB) had text highlighted in green to signify the areas on which initial agreement was reached and portions marked yellow indicating areas in which some form of convergence was reached. 

Plain text indicated areas regarding which no agreement was reached and bracketed text showed issues on which there were divergent views. 

Countries initially agreed on Article 12 regarding Pathogen Access and Benefit-Sharing System (PABS). It underscored the importance of promoting the rapid and timely sharing of materials and sequence information on pathogens with pandemic potential. They could not, however, fully accept the suggestion that PABS will be coordinated and convened by the World Health Organization (WHO).

Jean Kaseya, director general of Africa Centers for Disease Control and Prevention, said the continent wants this agreement, the New York Times reported. 

PABS is crucial for developing tests, vaccines and treatments rapidly, with African nations wanting equitable access. They also want local companies to manufacture medical products at a cheaper price. Western countries take some of their pathogens without sending them back the benefits, Kesaya added.

INB, which was established in late 2021, held nine meetings and discussed various iterations of a draft text for the next pandemic, which culminated in the outcome document that has now been submitted to the Health Assembly.

A new paragraph was added in the last draft that referred to the United Nations agreements giving nations sovereign rights over their genetic sequence database. 

It said: 

The provisions governing the PABS System shall be agreed such that they are consistent with, and do not run counter to the objectives of the Convention on Biological Diversity and its Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization, with the aim to recognise the PABS System, [with respect to Parties to the Nagoya Protocol and] [once fully developed] [and operational].

The countries also failed to agree on medical manufacturers’ terms of distribution to WHO in the event of a public health emergency of international concern. 

Through the Global Supply Chain and Logistics Network (GSCL Network), the draft proposed that manufacturers should at least provide 20 per cent of real-time production, no less than 10 per cent of production free of charge and 10 per cent of production at not-for-profit prices to WHO. This remains a bone of contention.

“Non-compliance with the new pandemic agreement risks another COVID-like pandemic, including inequitably distributed economic, social, and health consequences,” Nina Schwalbe of the think tank Spark Street told the news publication The Telegraph.

Experts have warned that the next pandemic’s source will likely be zoonotic. WHO has also recently cautioned that the spread of H5N1 is already a global zoonotic animal pandemic.

In parallel, WHO member states have also agreed to work during the assembly on finalising the package of amendments to the International Health Regulations (IHR) of 2005. It is the only legally binding response available in the face of deadly epidemics or pandemics and governments had proposed over 300 amendments. The IHR mandates that countries have surveillance systems and legal frameworks for countries to handle cross-border emergencies.

Though the agreement’s terms may not be decided, WHO said that member states would just agree on the timing, format and process to conclude the pandemic agreement in the future. Countries have not been able to reach an agreement because they believe the treaty would threaten their sovereignty and are unable to look at their national interests from a broad, humanitarian perspective.




Source link

Most Popular

To Top